OCT News and Research

RSS

Some health plans violate federal law requiring equal benefits for mental health care

One-quarter of the health plans being sold on health insurance exchanges set up through the Affordable Care Act offer benefits that appear to violate a federal law requiring equal benefits for general medical and mental health care, according to new research led by the Johns Hopkins Bloomberg School of Public Health.

3 Mar 2015

Clinical study comparing effectiveness of three standard treatments for DME published in NEJM

Regeneron Pharmaceuticals, Inc. today announced that results from the National Institutes of Health-sponsored, Diabetic Retinopathy Clinical Research Network comparative effectiveness study in patients with Diabetic Macular Edema (Protocol T) were published in the New England Journal of Medicine and a corresponding slide set was posted online at DRCR.net.

20 Feb 2015

Choroidal thickness reduced in diabetic macular oedema patients

Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.

13 Feb 2015

‘Earliest’ characteristics presaging drusen-associated atrophy identified

Researchers have used spectral-domain optical coherence tomography to identify specific pathological changes that precede the development of drusen-associated atrophy in patients with age-related macular degeneration.

13 Feb 2015

DePuy Synthes Spine receives 510(k) clearance to market SYNAPSE OCT System with posterior cervical screws

DePuy Synthes Spine today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SYNAPSETM Occipital-Cervical-Thoracic (OCT) System with posterior cervical screws, the first time cervical screws have been indicated for use with a screw-rod posterior fixation system.

29 Jan 2015

New Baylor research explores novel non-invasive technology for pediatric eye exams

Picture a toddler getting his first eye exam. He's seated in a strange room, with strange instruments and strange bright lights. He can't sit still or open his eyes long enough for that diagnostic poof of air - especially if he has trouble seeing anyway, as children with achromatopsia do.

23 Jan 2015

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. jointly announced today that the companies have entered into a collaboration agreement under which Carl Zeiss Meditec will provide funding to Oraya over a period of up to two years for the implementation of Oraya’s growth strategy, and in turn receive rights in the company reaching up to a majority stake after two years.

8 Jan 2015

Sugar-based molecular microcapsule eliminates toxicity of anticancer agent

Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue. The encapsulated drug packed a potent anticancer punch, stopping the progression of tumors in the mice, but without the usual toxic effects.

18 Dec 2014

Caution advised over OCT measurement of thick choroid

Enhanced depth imaging optical coherence tomography is consistent for measuring choroidal thickness, researchers confirm, but its accuracy may be impaired in eyes with a very thick choroid.

11 Dec 2014

Optical coherence tomography methods comparable for AMD assessments

There is good accordance between spectral-domain and time-domain optical coherence tomography image assessments of eyes treated for neovascular age-related macular degeneration, show study findings.

11 Dec 2014

OCT enhances neovascular subtype detection in AMD

Researchers recommend the inclusion of optical coherence tomography anatomic classification with fluorescein angiography grading to identify initial neovascular lesion subtypes in newly diagnosed age-related macular degeneration.

11 Dec 2014

Andor's Komet software used to automatically score modified 3D 'Comet' assay results

With cancer rates rising worldwide, and Cancer Research UK predicting that the lifetime risk of cancer will reach 50% by 2027, the need for early diagnosis is overwhelming. Now, a British research group has published details of a simple empirical test to detect any early-stage cancer, relying on Andor's Komet software to automatically score the modified 3D 'Comet' assay results.

From Andor Technology Ltd. 11 Dec 2014

Second treated eyes with nAMD functionally more important than first eyes

A real-world study of the characteristics of second treated eyes in patients with neovascular age-related macular degeneration given ranibizumab in the UK National Health Service has shown that these eyes start off with better baseline visual acuity than first treated eyes and, despite a poor response to therapy, maintain this advantage.

1 Dec 2014

Blocking key brain receptor cell could neutralize biological consequences of Alzheimer's

Blocking a key receptor in brain cells that is used by oxygen free radicals could play a major role in neutralizing the biological consequences of Alzheimer's disease, according to researchers at Temple University.

19 Nov 2014

Anxiety can accelerate conversion to Alzheimer's disease for people with mild cognitive impairment

People with mild cognitive impairment (MCI) are at increased risk of converting to Alzheimer's disease within a few years, but a new study warns the risk increases significantly if they suffer from anxiety.

11 Nov 2014

Stanford scientists find new way to predict progression of AMD

Stanford University School of Medicine scientists have found a new way to forecast which patients with age-related macular degeneration are likely to suffer from the most debilitating form of the disease.

6 Nov 2014

Hospira launches Paricalcitol Injection

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.

5 Nov 2014

U-M receives $1.6 million federal grant to study potential social and environmental links to autism

University of Michigan researchers will use a new $1.6 million federal grant to probe potential social and environmental links to autism, collecting location-specific information from tens of thousands of affected individuals and their families nationwide.

3 Nov 2014

Hospital bed positioning can affect outcomes of stroke patients

During the first 24 hours after a stroke, attention to detail --such as hospital bed positioning -- is critical to patient outcomes.

31 Oct 2014

$Adults with eczema at greater risk of accidental bone fractures, other injuries$

Adults with eczema at greater risk of accidental bone fractures, other injuries

Intense itching and dry, irritable skin aren't the only problems adults with eczema face. They are at greater risk of accidental bone fractures and other injuries, a new Northwestern Medicine® study has found.

31 Oct 2014

OCT News and Research

Some health plans violate federal law requiring equal benefits for mental health care

Clinical study comparing effectiveness of three standard treatments for DME published in NEJM

Choroidal thickness reduced in diabetic macular oedema patients

‘Earliest’ characteristics presaging drusen-associated atrophy identified

DePuy Synthes Spine receives 510(k) clearance to market SYNAPSE OCT System with posterior cervical screws

New Baylor research explores novel non-invasive technology for pediatric eye exams

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Sugar-based molecular microcapsule eliminates toxicity of anticancer agent

Caution advised over OCT measurement of thick choroid

Optical coherence tomography methods comparable for AMD assessments

OCT enhances neovascular subtype detection in AMD

Andor's Komet software used to automatically score modified 3D 'Comet' assay results

Second treated eyes with nAMD functionally more important than first eyes

Blocking key brain receptor cell could neutralize biological consequences of Alzheimer's

Anxiety can accelerate conversion to Alzheimer's disease for people with mild cognitive impairment

Stanford scientists find new way to predict progression of AMD

Hospira launches Paricalcitol Injection

U-M receives $1.6 million federal grant to study potential social and environmental links to autism

Hospital bed positioning can affect outcomes of stroke patients

Adults with eczema at greater risk of accidental bone fractures, other injuries

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News